| 
				Exhibition Hall  13:30 - 14:30  | 
			 
		 
		
			
				| 
				  | 
				
				  | 
				
				Computer # | 
			 
			
				
				 
  | 
				
				3380.    
				
				  | 
				
				73 | 
				
				
				
				Does tau pathology play a role in abnormal iron deposition in 
				Alzheimer’s Disease? A quantitative susceptibility mapping study 
				in the rTg4510 mouse model of Tauopathy  
					James O'Callaghan1, Holly Holmes1, 
					Nicholas Powell1, Jack Wells1, Ozama 
					Ismail1, Ian Harrison1, Bernard Siow1, 
					Michael O'Neill2, Emily Catherine Collins3, 
					Karin Shmueli4, and Mark Lythgoe1 
					1Centre for Advanced Biomedical Imaging, 
					University College London, London, United Kingdom, 2Eli 
					Lilly & Co. Ltd, Surrey, United Kingdom, 3Eli 
					Lilly and Company, Indianapolis, IN, United States,4Department 
					of Medical Physics and Biomedical Engineering, University 
					College London, London, United Kingdom 
				
					In this work, quantitative susceptibility mapping (QSM) and 
					T2* mapping were used to investigate iron accumulation both in-vivo and ex-vivo in 
					a mouse model of Alzheimer's Disease exhibiting tau 
					pathology for the first time.  Magnetic susceptibility 
					increases relative to controls were identified in grey 
					matter and white matter brain regions and may indicate 
					sensitivity to tissue iron content.  QSM in this mouse model 
					may therefore provide a non invasive method by which to 
					dissect the relationship between iron and tau pathology in 
					Alzheimer's Disease. 
				 
  | 
			 
			
				
				 
  | 
				
				3381.    
				
				  | 
				
				74 | 
				
				
				
				T2-weighted imaging of substantia nigra pars compacta shows 
				increased iron deposition in ventral lateral tier - Permission Withheld 
					Jason Langley1, Jan Sedlacik2, Daniel 
					E Huddleston3, Xiaoping Hu1, Jens 
					Fiehler2, and Kai Boelmans4 
					1Department of Biomedical Engineering, Emory 
					University & Georgia Tech, Atlanta, GA, United States, 2Department 
					of Neuroradiology, University Medical Center 
					Hamburg-Eppendorf (UKE), Hamburg, Germany, 3Department 
					of Neurology, Emory University, Atlanta, GA, United States, 4Department 
					of Neurology, University Medical Center Würzburg, Würzburg, 
					Germany 
				
					Recent results found that the SN seen in neuromenalnin 
					sensitive MRI and iron sensitive T2-weighted 
					contrasts is located in disparate spatial positions in 
					controls. Since iron is known to be deposited in the SN 
					after onset of Parkinson's disease(PD), we re-examine iron 
					sensitive measurements with respect to these new findings in 
					this abstract. Specifically, we find that the SN seen in T2-weighted 
					contrasts is enlarged in inferiorly and medially when 
					compared to controls. Most of this discrepancy happens in 
					the NM SN and we found the overlap to be an incredibly 
					sensitive marker for PD (p<10-15). 
				 
  | 
			 
			
				
				 
  | 
				
				3382.    
				
				  | 
				
				75 | 
				
				
				
				Association of Brain Iron Deposition in Parkinson’s Disease with 
				Comorbidities of Visual Hallucinations: An ROI-based 
				Quantitative Susceptibility Mapping Study  
					Darrell Ting Hung Li1, Edward Sai Kam Hui1, 
					Queenie Chan2, Nailin Yao3, Siew-eng 
					Chua4, Grainne M. McAlonan4,5, Shu 
					Leong Ho6, and Henry Ka Fung Mak1 
					1Department of Diagnostic Radiology, The 
					University of Hong Kong, Hong Kong, Hong Kong, 2Philips 
					Healthcare, Hong Kong, Hong Kong, 3Department 
					of Psychiatry, Yale University, New Haven, CT, United 
					States, 4Department 
					of Psychiatry, The University of Hong Kong, Hong Kong, Hong 
					Kong, 5Department 
					of Forensic and Neurodevelopmental Science, King’s College 
					London, London, United Kingdom, 6Department 
					of Medicine, The University of Hong Kong, Hong Kong, Hong 
					Kong 
				
					Abnormal iron accumulation in the brain may cause 
					oxidative-stress-induced neurodegeneration, which is one of 
					the hypothesis of nigral cell death in PD. It was also 
					believed that non-motor symptoms of PD patients are 
					associated with the increased of brain iron content. This 
					study examined the iron concentration in several subcortical 
					structures of PD patients with visual hallucinations by 
					using the QSM technique. Higher magnetic susceptibility was 
					observed in the hippocampus of this patient group. The 
					result supported the hypothesis that hippocampal abnormality 
					could induce visuospatial memory impairment which may be the 
					cause of visual hallucination in PD patients. 
				 
  | 
			 
			
				
				 
  | 
				
				3383.    
				
				  | 
				
				76 | 
				
				
				
				Evaluation of gray matter degeneration in Parkinson’s disease by 
				using neurite-orientation dispersion and density imaging: 
				Analysis by gray matter-based spatial statistics  
					Koji Kamagata1, Kouhei Tsuruta2, Taku 
					Hatano3, Keigo Shimoji4, Masaaki Hori1, 
					Ayami Okuzumi3, Misaki Nakazawa2, Syo 
					Murata2, Ryo Ueda2, and Shigeki Aoki1 
					1Department of Radiology, Juntendo University, 
					Tokyo, Japan, 2Department 
					of Radiological Sciences, Tokyo Metropolitan University, 
					Tokyo, Japan, 3Department 
					of Neurology, Juntendo University, Tokyo, Japan, 4Department 
					of Diagnostic Radiology, Tokyo Metropolitan Geriatric 
					Hospital, Tokyo, Japan 
				
					In this study, neurite-orientation dispersion and density 
					imaging were used to estimate structural changes of neurites 
					in the gray matter of the brain, which is the earliest 
					pathological change in patients with PD. The results showed 
					a significant decrease in the intracellular volume fraction 
					in the right amygdala and right putamen in PD, suggesting a 
					decrease in neurite density that may reflect actual 
					pathological change. Given that NODDI could detect 
					pathological changes at the earliest stages in PD, it may be 
					useful for early diagnosis. 
				 
  | 
			 
			
				
				 
  | 
				
				3384.    
				
				  | 
				
				77 | 
				
				
				
				Evaluation of different high-pass filter on the susceptibility 
				in patients Parkinson’s disease and controls  
					Gerd Melkus1,2, Santanu Chakraborty1,2, 
					and Fahad A Essbaiheen 1,2,3 
					1Medical Imaging, The Ottawa Hospital, Ottawa, 
					ON, Canada, 2Radiology, 
					University of Ottawa, Ottawa, ON, Canada, 3King 
					Saud University, Riyadh, Saudi Arabia 
				
					Quantitative susceptibility mapping (QSM) was found as a 
					useful method to evaluate neurodegenerative diseases such as 
					Parkinson’s disease. For QSM reconstruction background field 
					removed phase data is needed, but for retrospective studies 
					only high-pass filtered data might be available. In this 
					study we analyzed the influence of different high-pass 
					filtered phase images on the susceptibility assessment for 
					volunteers and Parkinson’s disease patients and compared the 
					results to QSM estimation using background field removed 
					phase data. With increasing high-pass filter strength 
					consistently lower susceptibility results, but up to a 
					certain filter strength differences in susceptibility can 
					still be distinguished. 
				 
  | 
			 
			
				
				 
  | 
				
				3385.    
				
				  | 
				
				78 | 
				
				
				
				Imaging effects of memantine treatment in a mouse model of 
				Huntington disease using evoked and resting-state fMRI  
					Wei-Tang Chang1, Fiftarina Puspitasari1, 
					Ling-Yun Yeow1, Hui-Chien Tay1, Marta 
					Garcia Miralles2, Katrianne Bethia Koh2, 
					Liang-Juin Tan2, Mahmoud POULADI2,3, 
					and Kai-Hsiang Chuang1 
					1SBIC, A*STAR, Singapore, Singapore, 2TLGM, 
					A*STAR, Singapore, Singapore, 3Department 
					of Medicine, National University of Singapore, Singapore, 
					Singapore 
				
					Huntington disease (HD) is an incurable neurodegenerative 
					disease. Recently, memantine (MMT) was found to be effective 
					delaying the progression of disease phenotypes in a mouse 
					model of HD. Here we applied resting-state fMRI to evaluate 
					functional connectivity in HD and the MMT treatment effect 
					and its behavioral correlates. The results of forepaw 
					stimulation reduced evoked responses though significance was 
					hampered by large individual variation. Interestingly, 
					functional connectivity outside of DMN, but not within DMN, 
					was decreased by HD. With MMT treatment, the connectivity 
					increased in general. The FC relevant to the behavioral test 
					also showed behavioral correlates. 
				 
  | 
			 
			
				
				 
  | 
				
				3386.    
				
				  | 
				
				79 | 
				
				
				
				Developmental White Matter Alterations in Monkey Brains with 
				Huntington’s Disease  
					Yuguang Meng1, Anthony W.S. Chan2,3, 
					and Xiaodong Zhang1,3 
					1Yerkes Imaging Center, Yerkes National Primate 
					Research Center, Emory University, Atlanta, GA, United 
					States, 2Department 
					of Human Genetics, School of Medicine, Emory University, 
					Atlanta, GA, United States, 3Division 
					of Neuropharmacology and Neurologic Diseases, Yerkes 
					National Primate Research Center, Emory University, Atlanta, 
					GA, United States 
				
					     This study examined the developmental changes of white 
					matter integrity in rhesus monkey brains with the HD gene 
					mutation using diffusion tensor imaging (DTI). Widespread 
					developmental alterations are seen in striatum, and the 
					frontal, motor, sensory and visual brain areas. The findings 
					reveal the temporal-spatial evolution of abnormal white 
					matter maturation during the development of the brain with 
					the Huntington’s Disease, and suggest altered neural 
					substrates associated with motor and cognitive dysfunctions 
					in HD patients. 
				 
  | 
			 
			
				
				 
  | 
				
				3387.    
				
				  | 
				
				80 | 
				
				
				
				Diffusion tensor imaging of the substantia nigra in Parkinson’s 
				disease revisited  
					Jason Langley1, Daniel E Huddleston2, 
					Michael Merritt1, Xiangchuan Chen1, 
					Rebecca McMurray2, Michael Silver2, 
					Stewart A Factor2, and Xiaoping Hu1 
					1Department of Biomedical Engineering, Emory 
					University & Georgia Tech, Atlanta, GA, United States, 2Department 
					of Neurology, Emory University, Atlanta, GA, United States 
				
					Inconclusive results from prior diffusion tensor 
					imaging-based studies can be attributed to variability in 
					location of regions of interest used to define the 
					substantia nigra and its subcomponents. We apply recent 
					findings from neuromelanin sensitive MRI to standardize 
					regions of interest for the substantia nigra. Differences in 
					fractional anisotropy and mean diffusivity were found in the 
					neuromelanin sensitive substantia nigra but not in the 
					substantia nigra defined in the b0 image. 
				 
  | 
			 
			
				
				 
  | 
				
				3388.    
				
				  | 
				
				81 | 
				
				
				
				Diagnosis of Parkinsonism Using Nigrosome 1 Imaging at 3T: 
				Comparison of Interobserver Agreement between GRE Magnitude 
				Images (MEDIC) and Susceptibility Map-weighted Images (SMWI)  
					Eung Yeop Kim1, Yoon Ho Nam2, Young 
					Noh3, Young Hee Sung3, Byeong Ho Goh1, 
					Joon Hyung Ann1, and Jongho Lee4 
					1Radiology, Gachon University Gil Medical Center, 
					Incheon, Korea, Republic of, 2Radiology, 
					Seoul St. Mary Hospital, Seoul, Korea, Republic of, 3Neurology, 
					Gachon University Gil Medical Center, Incheon, Korea, 
					Republic of, 4Electrical 
					and Computer Engineering, Seoul National University, Seoul, 
					Korea, Republic of 
				
					Susceptibility map-weighted imaging (SMWI) improves both CNR 
					and SNR in comparison with conventional SWI. In this work, 
					we compared SMWI with MEDIC (a multi-echo GRE imaging that 
					combines magnitude images via sum of squares) for nigrosome 
					1 imaging at 3T in terms of interobserver agreement and 
					diagnostic performance in 74 subjects (44 with Parkinson’s 
					disease). Two experienced and two less-experienced reviewers 
					visually assessed both imaging sets separately. Compared 
					with MEDIC, SMWI showed higher kappa values and larger AUCs, 
					regardless of level of experience. As a result, nigrosome 1 
					imaging using SMWI significantly improved diagnostic 
					performance as well as interobserver agreement. 
				 
  | 
			 
			
				
				 
  | 
				
				3389.    
				
				  | 
				
				82 | 
				
				
				
				Sensitivity of volumetric MRI and MRS to onset and progression 
				of neurodegeneration  
					Dinesh K Deelchand1, James M Joers1, 
					Adarsh Ravishankar2, Tianmeng Lyu3, 
					Uzay Emir1,4, Diane Hutter1, 
					Christopher M Gomez5, Khalaf O Bushara6, 
					Christophe Lenglet1, Lynn E Eberly3, 
					and Gulin Oz1 
					1Center for Magnetic Resonance Research, 
					University of Minnesota, Minneapolis, MN, United States, 2School 
					of Physics and Astronomy, University of Minnesota, 
					Minneapolis, MN, United States,3Division of 
					Biostatistics, University of Minnesota, Minneapolis, MN, 
					United States, 4University 
					of Oxford, Oxford, United Kingdom, 5Department 
					of Neurology, University of Chicago, Chicago, IL, United 
					States, 6Department 
					of Neurology, University of Minnesota, Minneapolis, MN, 
					United States 
				
					The goal of this study was to combine MRS with volumetric 
					MRI to determine the sensitivity of these two techniques to 
					onset and progression of neurodegeneration in patients with 
					early-moderate spinocerebellar ataxia type 1. Subjects were 
					scanned at baseline and followed up at ~18 and ~36 months at 
					3T. Both MRI and MRS measures were found to be more 
					sensitive to disease progression than standardized clinical 
					scores. This study shows that volumetric MRI was most 
					sensitive to disease progression while MRS might be more 
					sensitive to detect the disease’s early stage. 
				 
  | 
			 
			
				
				 
  | 
				
				3390.    
				
				  | 
				
				83 | 
				
				
				
				QSM and T2* Mapping in a Six Month Placebo-Controlled Clinical 
				Trial of the Iron Chelator Deferiprone in Parkinson’s Disease  
					Rexford Newbould1, Courtney Bishop1, 
					Antonio Martin-Bastida2, and David Dexter2 
					1Imanova Centre for Imaging Sciences, London, 
					United Kingdom, 2Imperial 
					College London, London, United Kingdom 
				
					A double-blind placebo-controlled clinical trial of an iron 
					chelation therapy was performed in 25 subjects with 
					Parkinson’s disease (PD) and 12 healthy matched controls.  
					Two MRI measures of brain iron at each of three visits at 
					baseline, 3 months, and 6 months were derived from a high 
					resolution 3D multiecho volume: T2* and QSM maps. T2* values 
					significantly lengthened in six of nine pre-defined ROIs by 
					the final visit in the highest dose group.  QSM values , 
					however, did not change with treatment.  This differential 
					trajectory between relaxation and susceptibility may result 
					from ferritin’s complex relaxation behavior. 
				 
  | 
			 
			
				
				 
  | 
				
				3391.    
				
				  | 
				
				84 | 
				
				
				
				Characterizing neurodegeneration in progressive supranuclear 
				palsy using VBM and SVM classification  
					Karsten Mueller1, Robert Jech2,3, 
					Cecilia Bonnet2,3, Jaroslav Tintera4, 
					Harald E Möller1, Klaus Fassbender5, 
					Jan Kassubek6, Markus Otto6, Evžen 
					Ružicka2,3, and Matthias L Schroeter1,7 
					1Max Planck Institute for Human Cognitive and 
					Brain Sciences, Leipzig, Germany, 2Department 
					of Neurology and Center of Clinical Neuroscience, Charles 
					University in Prague, Prague, Czech Republic,31st 
					Faculty of Medicine and General University Hospital in 
					Prague, Prague, Czech Republic, 4Institute 
					for Clinical and Experimental Medicine, Prague, Czech 
					Republic, 5Clinic 
					and Polyclinic for Neurology, Saarland University Homburg, 
					Homburg, Germany, 6Clinic 
					and Polyclinic for Neurology, University of Ulm, Ulm, 
					Germany, 7Clinic 
					for Cognitive Neurology, University Hospital Leipzig, 
					Leipzig, Germany 
				
					Structural brain differences were investigated between 
					patients with progressive supranuclear palsy (PSP) and 
					healthy controls with T1-weighted images (MP-RAGE) acquired 
					at four centers with different 3T scanners (Siemens). Using 
					voxel-based morphometry, we found a major decline in gray 
					matter density in brainstem, insula, striatum, and 
					frontomedian regions that is in line with the current 
					literature. Support-vector-machine classification provided a 
					high sensitivity of disease detection when using relevant 
					brain regions in feature selection. 
				 
  | 
			 
			
				
				 
  | 
				
				3392.    
				
				  | 
				
				85 | 
				
				
				
				Robust global and widespread local white matter abnormalities in 
				a longitudinal study of juvenile neuronal ceroid lipofuscinosis 
				(CLN3)  
					Ulrika Roine1, Timo Roine2,3, Antti 
					Hakkarainen3, Anna Tokola3, Marja H. 
					Balk3, Minna Mannerkoski4, Tuula 
					Lönnqvist5, and Taina Autti3 
					1Department of Neuroscience and Biomedical 
					Engineering, Aalto University, Espoo, Finland, 2iMinds-Vision 
					Lab, Department of Physics, University of Antwerp, Wilrijk 
					(Antwerp), Belgium, 3HUS 
					Medical Imaging Center, Radiology, University of Helsinki 
					and Helsinki University Hospital, Helsinki, Finland, 4Child 
					Psychiatry, University of Helsinki and Helsinki University 
					Hospital, Helsinki, Finland,5Department of Child 
					Neurology, Children's Hospital, University of Helsinki and 
					Helsinki University Hospital, Helsinki, Finland 
				
					Juvenile neuronal ceroid lipofuscinosis (CLN3), is a 
					progressive neurodegenerative lysosomal storage disease of 
					the childhood, which manifests with loss of vision, 
					seizures and loss of cognitive and motor functions, and 
					leads to premature death. We investigated global and local 
					white matter microstructure with diffusion MRI in 14 
					children with CLN3 imaged at two time points. Robust global 
					analysis was performed using whole-brain tractography and 
					white matter tract skeleton. Local microstructural 
					abnormalities were investigated using tract-based spatial 
					statistics. Significantly decreased fractional anisotropy 
					and increased diffusivity values were found in subjects with 
					CLN3 both at the global and local scale. 
				 
  | 
			 
			
				
				 
  | 
				
				3393.    
				
				  | 
				
				86 | 
				
				
				
				Structural brain connectome and cognitive impairment in 
				Parkinson’s disease - Permission Withheld 
					Sebastiano Galantucci1, Federica Agosta1, 
					Elka Stefanova2, Silvia Basaia1, 
					Martijn van den Heuvel3, Tanja Stojkovic2, 
					Elisa Canu1, Iva Stankovic2, Vladana 
					Spica2, Vladimir S. Kostic2, and 
					Massimo Filippi1,4 
					1Neuroimaging Research Unit, San Raffaele 
					Scientific Institute, Vita-Salute San Raffaele University, 
					Milan, Italy, 2Clinic 
					of Neurology, Faculty of Medicine, University of Belgrade, 
					Belgrade, Yugoslavia,3Department of Psychiatry, 
					Rudolf Magnus Institute of Neuroscience, University Medical 
					Center Utrecht, Utrecht, Netherlands, 4Department 
					of Neurology, San Raffaele Scientific Institute, Vita-Salute 
					San Raffaele University, Milan, Italy 
				
					To date, MRI biomarkers have been demonstrated extremely 
					useful for detecting and monitoring the neurodegenerative 
					processes. However, brain network analysis seems the most 
					powerful approach to quantitatively describe the topological 
					organization of the brain connectome even at early stages of 
					neurodegenerative diseases.  This study provided promising 
					biomarkers to detect features of neurodegeneration in 
					PD-MCI, being able to distinguish it from PD without MCI. 
					This study shows that the presence of subtle cognitive 
					deficits not causing a dementia, produces a huge alteration 
					of brain networks suggesting the importance of the study of 
					connectomics in the investigation of neurodegenerative 
					diseases. 
				 
  | 
			 
			
				
				 
  | 
				
				3394.    
				
				  | 
				
				87 | 
				
				
				
				fMRI reveals plasticity compensating for early dopaminergic loss 
				at corticostriatal synapse  
					Chiao-Chi Chen1, Yi-Hua Hsu1, Nai-Wei 
					Yao1, and Chen Chang1 
					1Institute of Biomedical Sciences, Academia 
					Sinica, Taipei, Taiwan 
				
					The dopaminergic system possesses striking plasticity 
					compensating for motor aberrations from neuronal loss. 
					Little is known regarding the compensation mechanism during 
					dopaminergic loss, preventing the aberration from being 
					arrested and treated early. Here we present in vivo imaging 
					evidence from functional magnetic resonance imaging showing 
					that, after dopaminergic depletion, the dorsolateral 
					striatum (DOLS) exhibited an early and transient 
					vasodilation cluster in response to specific forepaw 
					stimulation. Activation of DOLS NMDA receptors causes this 
					vasodilation, protects dopaminergic fibers from denervation, 
					and counteracts motor deficits. The findings have clinical 
					implications for early detection and intervention in brain 
					disorders such as Parkinson’s disease. 
				 
  | 
			 
			
				
				 
  | 
				
				3395.    
				
				  | 
				
				88 | 
				
				
				
				Dopaminergic therapy modulates cortical perfusion in Parkinson’s 
				disease with and without dementia according to ASL perfusion MRI  
					Chien-Yuan Eddy Lin1, Wei-Che Lin2, 
					Pei-Chin Chen2, Yung-Cheng Huang3, 
					Nai-Wen Tsai4, Hsiu-Ling Chen2, 
					Hung-Chen Wang5, Tsu-Kung Lin4, 
					Kun-Hsien Chou6, Meng-Hsiang Chen2, 
					Yi-Wen Chen2, and Cheng-Hsien Lu4 
					1GE Healthcare, Taipei, Taiwan, 2Department 
					of Diagnostic Radiology, Kaohsiung Chang Gung Memorial 
					Hospital, Kaohsiung, Taiwan, 3Department 
					of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, 
					Kaohsiung, Taiwan, 4Department 
					of Neurology, Kaohsiung Chang Gung Memorial Hospital, 
					Kaohsiung, Taiwan, 5Department 
					of Nuerosurgery, Kaohsiung Chang Gung Memorial Hospital, 
					Kaohsiung, Taiwan, 6Brain 
					Research Center, National Yang-Ming University, Taipei, 
					Taiwan 
				
					We examined the cerebral perfusion differences among 17 
					Parkinson’s disease (PD) patients, 17 PD with dementia (PDD) 
					patients, and 17 healthy controls and used noncontrast 
					arterial spin labelling MRI to assess the effects of 
					dopaminergic therapies on perfusion in the patients. We 
					demonstrated progressive widespread cortical hypoperfusion 
					in PD and PDD and robust effects for the dopaminergic 
					therapies. These patterns of hypoperfusion could be related 
					to cognitive dysfunctions and disease severity. Furthermore, 
					desensitization to dopaminergic therapies in terms of 
					cortical perfusion was found as the disease progressed, 
					supporting the concept that long-term therapies are 
					associated with the therapeutic window narrowing. 
				 
  | 
			 
			
				
				 
  | 
				
				3396.    
				
				  | 
				
				89 | 
				
				
				
				Aberrant interhemispheric structural and functional connectivity 
				in amyotrophic lateral sclerosis: converging evidences from DTI 
				and resting-state fMRI - Permission Withheld 
					Jiuquan Zhang1,2, Bing Ji2,3, Zhihao 
					Li2, Jun Hu4, Jian Wang1, 
					Mingze Xu5, and Xiaoping Hu2 
					1Department of Radiology, Southwest Hospital, 
					Chongqing, China, People's Republic of, 2Department 
					of Biomedical Engineering, Emory University & Georgia 
					Institute of Technology, Atlanta, GA, United States, 3University 
					of Shanghai for Science & Technology, Shanghai, China, 
					People's Republic of, 4Department 
					of Neurology, Southwest Hospital, Chongqing, China, People's 
					Republic of, 5Department 
					of Biomedical Engineering, Perking University, Beijing, 
					China, People's Republic of 
				
					The corpus callosum (CC) involvement is a consistent feature 
					of Amyotrophic lateral sclerosis (ALS), thus suggesting a 
					pathopysiology of reduced interhemispheric neural 
					connectivity. In the current study, we directly examined the 
					interhemispheric functional and structural connectivities in 
					ALS. In terms of functional connectivity, extensive 
					alterations in voxel mirrored homotopic connectivity were 
					found in ALS. With structural connectivity, while there were 
					widespread reductions in DTI metrics, only the fiber 
					probability index through CC subregion III in the ALS 
					patients was significantly decreased compared with the 
					controls. These findings provide further evidence for 
					structural and functional interhemispheric connectivity 
					impairment in ALS. 
				 
  | 
			 
			
				
				 
  | 
				
				3397.    
				
				  | 
				
				90 | 
				
				
				
				Investigation of inter-hemispheric functional connectivity in 
				Parkinson's disease with asymmetric onset using Voxel-Mirrored 
				Homotopic Connectivity  
					Yong Zhang1, Naying He2, Hua-Wei Lin2, 
					Ajit Shankaranarayanan3, Zhenyu Zhou1, 
					and Fu-Hua Yan2 
					1MR Research China, GE Healthcare, Beijing, 
					China, People's Republic of, 2Radiology, 
					Ruijin Hospital, Shanghai Jiaotong University School of 
					Medicine, Shanghai, China, People's Republic of, 3GE 
					Healthcare, Menlo Park, CA, United States 
				
					This preliminary study used voxel-mirrored homotopic 
					connectivity (VMHC), a novel resting-state fMRI parameter to 
					investigate inter-hemispheric functional connectivity in 
					Parkinson’s Disease (PD) with asymmetric onset. Fifteen left 
					side onset (LPD) patients, sixteen right side onset (RPD) 
					patients and nineteen healthy controls were recruited for 
					comparison. Both of LPD and RPD patients showed decreased 
					VMHC in post-central gyrus responsible for motor functions. 
					The decreased VMHC in the cuneus and middle occipital gyrus 
					in LPD patients might affect visual processing function. For 
					RPD patients, VMHC changes in the middle and superior 
					frontal gyrus could be relevant to advanced cognitive 
					impairment. 
				 
  | 
			 
			
				
				 
  | 
				
				3398.    
				
				  | 
				
				91 | 
				
				
				
				Can longitudinal diffusion-weighted imaging of the basal ganglia 
				be used as a surrogate marker in preclinical Huntington’s 
				disease?  
					Chris Patrick Pflanz1, Marina Charquero-Ballester2, 
					Adnan Majid3, Anderson Winkler1, 
					Emmanuel Vallee1, Mark Jenkinson1, 
					Adam Aron3, and Gwenaelle Douaud1 
					1FMRIB Centre, University of Oxford, Oxford, 
					United Kingdom, 2Oxford, 
					United Kingdom, 3San 
					Diego, CA, United States 
				
					Huntington’s disease is a monogenetic, 
					neurodegenerative movement disorder that is amenable to 
					predictive genetic testing.  Here, we investigated whether 
					longitudinal diffusion-weighted imaging of the basal ganglia 
					could be used to detect early microstructural changes in 
					participants with presymptomatic Huntington’s disease 
					(preHD). We found the first results showing significant 
					longitudinal changes in the microstructure of the basal 
					ganglia within a 
					preclinical HD population. We further showed that, while FA 
					and MD might be less sensitive to longitudinal changes than 
					volumetric measures, they provide mechanistic insights into 
					the underlying physiopathological process that are 
					complementary to the monotonic, non-specific changes in the 
					volume of the basal ganglia. 
				 
  | 
			 
			
				
				 
  | 
				
				3399.    
				
				  | 
				
				92 | 
				
				
				
				Brain Iron Deficiency in Restless Legs Syndrome Measured by 
				Quantitative Susceptibility and its Relation to Clinical 
				Features  
					Xu Li1,2, Hongjun Liu1,2, Richard P 
					Allen3, Christopher J Earley3, Richard 
					A.E. Edden1,2, Peter B Barker1,2, 
					Tiana Cruz3, and Peter C.M. van Zijl1,2 
					1F.M. Kirby Research Center for Functional Brain 
					Imaging, Kennedy Krieger Institute, Baltimore, MD, United 
					States, 2Radiology, 
					Johns Hopkins University School of Medicine, Baltimore, MD, 
					United States,3Neurology, Johns Hopkins 
					University School of Medicine, Baltimore, MD, United States 
				
					Possible brain iron deficiency was assessed using 
					quantitative susceptibility mapping at 7T in restless legs 
					syndrome (RLS) and analyzed with clinical measurements 
					including IRLS severity score, serum iron, serum ferritin 
					and periodic limb movement during sleep (PLMS). Using 
					magnetic susceptibility as a brain iron index and compared 
					to control group, significantly decreased iron was found in 
					RLS patients in dentate nuclei and thalamus, and in 
					substantia nigra in a subset of RLS patients with severe 
					clinical symptoms with PLMS larger than 100 times per hour. 
					Significant correlation between PLMS and brain iron was only 
					found in substantia nigra in RLS. 
				 
  | 
			 
			
				
				 
  | 
				
				3400.    
				
				  | 
				
				93 | 
				
				
				
				Quantitative Susceptibility Mapping of the “Swallow tail” in 
				Parkinson disease  
					Santanu Chakraborty1,2, Gerd Melkus1,2, 
					Fahad Essbaiheen1,2,3, David A Grimes4, 
					and Tiago Mestre4 
					1Medical Imaging, The Ottawa Hospital, Ottawa, 
					ON, Canada, 2Radiology, 
					University of Ottawa, Ottawa, ON, Canada, 3King 
					Saud University, Riyadh, Saudi Arabia, 4Neurology, 
					The Ottawa Hospital, Ottawa, ON, Canada 
				
					Parkinson disease (PD) continues to be diagnosed based on 
					clinical findings. Recently, in SWI images, the loss of 
					‘swallow tail’ appearance in dorsolateral substantia nigra 
					in PD patients yielded high diagnostic accuracy. In our 
					study we measured susceptibility values using QSM in the 
					‘swallow tail’ area in seven Parkinson’s disease patients 
					and compared to five control subjects. The susceptibility in 
					the swallow tail area was higher in the PD group (0.072 vs. 
					0.058). This likely suggests increased iron deposition 
					causing a masking effect that contributes along with 
					dopaminergic neurons loss to the disappearance of the 
					‘swallow tail’ in PD patients. 
				 
  | 
			 
			
				
				 
  | 
				
				3401.    
				
				  | 
				
				94 | 
				
				
				
				MRI signatures in the brain of patients with PD and iRBD  
					Silvia Mangia1, Philip Burton1, Alena 
					Svatkova2,3, Igor Nestrasil4, 
					Alejandra Sierra Lopez5, Karin Shmueli6, 
					Lynn Eberly7, Michael Howell4, Paul 
					Tuite4, and Shalom Michaeli1 
					1CMRR, Department of Radiology, University of 
					Minnesota, Minneapolis, MN, United States, 2Department 
					of Pediatrics, University of Minnesota, Minneapolis, MN, 
					United States, 3Central 
					European Institute of Technology (CEITEC), Masaryk 
					University, Brno, Czech Republic, 4Department 
					of Neurology, University of Minnesota, Minneapolis, MN, 
					United States, 5A.I.Virtanen 
					Institute for Molecular Sciences, University of Eastern 
					Finland, Kuopio, Finland, 6Department 
					of Medical Physics and Biomedical Engineering, University 
					College London, London, United Kingdom, 7Division 
					of Biostatistics, University of Minnesota, Minneapolis, MN, 
					United States 
				
					The idiopathic rapid eye movement sleep behavior disorder 
					(iRBD) is a condition that often evolves into Parkinson’s 
					disease (PD), therefore by monitoring iRBD one can track the 
					neurodegeneration of individuals that may progress to PD. 
					Here we used a battery of MRI contrasts to characterize 
					brain tissue properties such as microstructural integrity, 
					iron loads, and functional connectivity in 10 iRBD, 10 PD 
					and 10 age-matched healthy subjects. Rotating frame 
					relaxation methods adiabatic T1,2ρ and 
					RAFFn, along with DTI and rsfMRI detected heterogeneous 
					abnormalities in several subcortical structures of PD and 
					iRBD subjects. 
				 
  | 
			 
			
				
				 
  | 
				
				3402.    
				
				  | 
				
				95 | 
				
				
				
				A High b-Value Diffusion Study of Brainstem Abnormality in 
				Patients with Parkinson's Disease Using a CTRW Model  
					Zheng Zhong1,2, Muge Karaman1, Douglas 
					Merkitch3, Jennifer Goldman3, and 
					Xiaohong Joe Zhou1,4 
					1Center for MR Research, Chicago, IL, United 
					States, 2Bioengineering, 
					University of Illinois at Chicago, Chicago, IL, United 
					States, 3Neurological 
					Sciences, Rush University Medical Center, Chicago, IL, 
					United States, 4Radiology, 
					Neurosurgery and Bioengineering, University of Illinois 
					Hospital & Health Sciences system, Chicago, IL, United 
					States 
				
					It has been known that the substantia nigra of brain stem 
					shows structural abnormalities with the progression of 
					Parkinson’s disease. While high b-value diffusion imaging 
					has the potential to reveal such structural changes, 
					single-shot EPI suffers from unwanted geometric distortion 
					which may result in poor analysis of the diffusion data. In 
					this study, we use a recently developed reduced field of 
					view imaging technique and analyze the abnormalities 
					occurring in the substantia nigra of the Parkinson’s disease 
					patients by using the continuous-time random-walk (CTRW) 
					model. 
				 
  | 
			 
			
				
				 
  | 
				
				3403.    
				
				  | 
				
				96 | 
				
				
				
				The Effect of Primidone on Gamma-Aminobutyric Acid Concentration 
				in the Dentate Nucleus in Patients with Essential Tremor  
					Ulrike Dydak1,2, Ruoyun Ma1,2, Nora 
					Hernandez3, Johnathan P Dyke4, and 
					Elan Louis3,5,6 
					1School of Health Sciences, Purdue University, 
					West Lafayette, IN, United States, 2Department 
					of Radiology and Imaging Sciences, Indiana University School 
					of Medicine, Indianapolis, IN, United States,3Department 
					of Neurology, Yale School of Medicine, New Heaven, CT, 
					United States, 4Department 
					of Radiology, Weill Cornell Medical College, New York, NY, 
					United States, 5Center 
					for Neuroepidemiology and Clinical Neurological Research, 
					Yale School of Medicine, New Heaven, CT, United States, 6Department 
					of Chronic Disease Epidemiology, Yale School of Public 
					Health, New Heaven, CT, United States 
				
					Whether current use of the medication primidone affects 
					dentate γ-aminobutyric acid (GABA) concentrations is 
					unknown. Yet, this may be an important confounder in studies 
					of the pathophysiology of essential tremor (ET). Using the 
					MEGA-PRESS J-editing sequence, we found no difference in 
					dentate GABA levels between patients taking primidone and 
					patients not taking primidone. Furthermore, there was no 
					association between daily primidone dose and dentate GABA 
					concentration. These data suggest that it is not necessary 
					to exclude ET patients on primidone from MRS studies of 
					dentate GABA concentration. 
				 | 
			 
		 
		 |